Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01187680
Other study ID # RU-RTB-0002
Secondary ID
Status Terminated
Phase Phase 4
First received July 19, 2010
Last updated December 28, 2010
Start date October 2002
Est. completion date July 2009

Study information

Verified date August 2010
Source Radboud University
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate whether sprayable PEG barrier is effective in reducing adhesions in laparoscopic gynecologic surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 16
Est. completion date July 2009
Est. primary completion date April 2004
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- >18 years

- Undergoing gynecologic laparoscopy

Exclusion Criteria:

- Suspected malignancy

- Incomplete adhesiolysis during initial laparoscopy

- Pregnancy

- Lactating

- Stage IV endometriosis

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Intervention

Device:
Spraygel

Control
Good surgical technique, no adhesion barrier

Locations

Country Name City State
Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam Noord-Holland

Sponsors (2)

Lead Sponsor Collaborator
Radboud University Onze Lieve Vrouwe Gasthuis

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary successful adhesion prevention Adhesion prevention was defined as successful if no de novo fromed adhesion were found at second look laparoscopy. No
Secondary LABS adhesion score No
Secondary Adhesion sites Reduction in the number of sites covered with adhesions No
See also
  Status Clinical Trial Phase
Completed NCT02773251 - The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery: Randomized, Prospective, Multicenter Study Phase 4
Not yet recruiting NCT06282354 - Telemedicine for Postoperative Follow-up After Oncological Surgeries